Jiang Yuan-bin, Gou Xin
Department of Urology, The First Affiliated Hospital of Chongging Medical University, Chongqing 400016, China.
Zhonghua Nan Ke Xue. 2009 Oct;15(10):937-40.
Erectile dysfunction (ED) commonly results from endothelial dysfunction and erectile nerve damage. Recent researches have focused on the preclinical studies of stem cell-based therapies targeted at repairing penile endothelium and protecting erectile nerves. Early studies showed that stem cell- or gene-modified stem cell-based therapies may have enduring efficacy and eventually lead to a cure for ED. Such stem cells as embryonic, mesenchymal, muscle-derived and adipose-derived ones and endothelial progenitor cells all have differentiation potentials and obvious advantages in protecting and repairing both nervi erigentes and corpus cavernosum vascular endothelial cells. Stem cell-based therapies promise to be an effective approach to human erectile dysfunction.
勃起功能障碍(ED)通常由内皮功能障碍和勃起神经损伤引起。最近的研究集中在针对修复阴茎内皮和保护勃起神经的基于干细胞疗法的临床前研究上。早期研究表明,基于干细胞或基因修饰干细胞的疗法可能具有持久疗效,并最终治愈ED。诸如胚胎干细胞、间充质干细胞、肌肉来源干细胞、脂肪来源干细胞和内皮祖细胞等干细胞在保护和修复海绵体神经和海绵体血管内皮细胞方面均具有分化潜能和明显优势。基于干细胞的疗法有望成为治疗人类勃起功能障碍的有效方法。